Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

RMJ. 2023; 48(3): 568-570


What's Making a COVID-19 a dangerous disease for long time?

Diaa K. Abd Ali, Ahmed Mohammed Jasim Shlash, Mohammed H. Shamran, Ibrahim A. Al-Ashour.




Abstract

Objective: To evaluate COVID-19 complications among recovered patients and determine the association between these complications and patients' demographic data.
Methodology: This descriptive retrospective study was conducted from December 15th, 2021 to May 1st, 2022 in the city of Al-Najaf. A convenience (non-probability) sampling was used and 157 patients with COVID-19 disease were enrolled. The information was gathered using a specially designed questionnaire that was divided into three sections: sociodemographic traits, medical history, and the systematic COVID-19 Complications.
Results: Out of 157 patients, 73 were women and 84 men. Even after recovering from COVID-19, the patients continue to experience difficulties. Acute respiratory failure (46.5%), pneumonia (15.35%), blood hypercoagulability (35.7%), diarrhea (33.1%), myalgias (19.1%), and arthralgias (15.3%) were the most frequent consequences.
Conclusion: The study concluded that COVID-19 is a deadly virus that affects every system of the body and might lead to serious consequences that could endanger the patients' lives.

Key words: COVID-19, complications, acute respiratory failure, blood coagulability.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.